Company Overview
Arxis, Inc. designs and manufactures electronic and mechanical components for mission critical applications in the United States. The company operates through two segments: Electronic Components and Mechanical Components. Its Electronic Components segment provides engineered electronic components and interconnect solutions, including connectors, cable assemblies, microelectronic packaging, radio frequency (RF) and microwave products, power products, sensors, capacitors. and resistors. The Mechanical Components segment offers precision and self-lubricating bearings, seals, springs, gaskets and ducting, and radar absorbing materials. It serves defense and space systems, commercial aerospace platforms, medical technology, semiconductor testing, analytical devices, industrial automation, and other specialized industrial sectors. The company was founded in 2019 and is based in Bloomfield, Connecticut.
Why Investors Should Care
Revenue has grown at a 94.2% CAGR over the past five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $1.60B (+115.5% YoY); net profit $-49.83M.
- Trailing 12 Months Year-on-year growth — revenue +25.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 94.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 94.21% |
| 1 Year: | 25.00% |
Stock Price Performance
| 1 Year: | +37.26% |
| 6 Months: | - |
| 3 Months: | +30.98% |
| 1 Month: | -11.34% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- RSI (14)52.23 · Neutral
P/E of 759.86 is above the sector median of 26.00 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 94.2% over 5 years.
- Generates positive free cash flow.
CONS
- Trading at a high P/E of 759.9.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Industrials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ARXS Arxis, Inc. DEFENCE | 53.19 | 759.86 | $4.80B | 0.00% | 1.62% | -1.19% | 94.21% | - |
| 2 | SPCX Space Exploration Technologies Corp. R3KAIDEFENCE | 153.47 | -139.52 | $1.16T | 0.00% | -3.22% | -11.95% | 34.08% | -3.34% |
| 3 | CAT Caterpillar Inc. SPXR3K | 822.48 | 35.47 | $378.07B | 0.79% | 17.98% | 56.97% | 2.29% | 5.24% |
| 4 | GE GE Aerospace SPXR3KDEFENCE | 334.91 | 39.40 | $347.49B | 0.60% | 9.52% | 48.23% | -7.42% | -5.36% |
| 5 | RTX RTX Corporation SPXR3KDEFENCE | 198.81 | 35.06 | $267.95B | 1.51% | 8.28% | 12.27% | 2.61% | 2.62% |
| 6 | GEV GE Vernova Inc. SPXR3KAI | 971.31 | 27.86 | $258.69B | 0.22% | 6.30% | 82.58% | 8.68% | - |
| 7 | DE Deere & Company SPXR3K | 680.73 | 37.88 | $183.54B | 0.95% | 12.53% | 18.24% | 3.43% | 5.10% |
| 8 | UNP Union Pacific Corporation SPXR3K | 288.45 | 23.38 | $171.36B | 2.01% | 15.22% | 39.70% | 2.30% | 7.77% |
| 9 | BA The Boeing Company SPXR3KDEFENCE | 210.73 | 75.80 | $166.43B | 0.00% | -9.01% | - | 1.67% | -3.28% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 380.08M | 400.44M | 458.86M | 500.73M |
| Cost of Revenue | 217.17M | 202.83M | 224.01M | 238.13M |
| Gross Profit | 162.91M | 197.61M | 234.84M | 262.60M |
| Operating Expenses | 102.71M | 114.76M | 124.34M | 229.92M |
| Operating Income | 60.20M | 82.85M | 110.50M | 32.68M |
| EBITDA | 110.43M | 135.54M | 164.50M | 90.04M |
| Interest Expense | 68.26M | 57.36M | 43.96M | 39.43M |
| Pretax Income | -6.83M | 29.09M | 69.01M | -1.41M |
| Tax Provision | -2.50M | 58.34M | 15.70M | 3.50M |
| Net Income | -4.32M | -29.26M | 53.31M | -4.91M |
| Diluted EPS | -0.01 | -0.07 | 0.13 | -0.01 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | 424.50M | 742.99M | 1.60B |
| Cost of Revenue | 230.48M | 411.85M | 843.01M |
| Gross Profit | 194.02M | 331.14M | 758.06M |
| Operating Expenses | 139.70M | 228.55M | 650.15M |
| Operating Income | 54.32M | 102.59M | 107.91M |
| EBITDA | 120.49M | 204.35M | 313.98M |
| Interest Expense | 124.50M | 161.05M | 178.51M |
| Pretax Income | -69.33M | -53.00M | -64.64M |
| Tax Provision | -9.41M | 2.47M | -14.81M |
| Net Income | -59.92M | -55.47M | -49.83M |
| Diluted EPS | -0.15 | -0.14 | -0.12 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Total Assets | 6.32B | 6.90B |
| Current Assets | 712.06M | 1.21B |
| Cash & Equivalents | 110.84M | 561.36M |
| Inventory | 301.95M | 315.60M |
| Receivables | 198.96M | 216.94M |
| Total Liabilities | 3.34B | 2.70B |
| Current Liabilities | 263.02M | 240.09M |
| Long Term Debt | 2.51B | 1.88B |
| Total Debt | 2.59B | 1.96B |
| Total Equity | 2.98B | 4.20B |
| Shares Outstanding | 404.33M | 404.33M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating Cash Flow | -7.92M | 70.95M | 251.20M |
| Investing Cash Flow | -12.19M | -35.28M | -192.82M |
| Financing Cash Flow | 15.58M | 62.23M | 78.11M |
| Capital Expenditure | -12.50M | -28.89M | -42.42M |
| Free Cash Flow | -20.42M | 42.06M | 208.77M |
| Net Change in Cash | -4.53M | 97.90M | 136.48M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Gross Margin % | 45.7% | 44.6% | 47.3% |
| Operating Margin % | 12.8% | 13.8% | 6.7% |
| Net Margin % | -14.1% | -7.5% | -3.1% |
| ROE % | - | -1.9% | -1.2% |
| ROCE % | - | 1.7% | 1.6% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | T. Rowe Price Investment Management, Inc. | 6.68% | 5.13M | $267.04M |
| 2 | Jupiter Topco LLC | 5.88% | 4.52M | $234.97M |
| 3 | Capital International Investors | 4.69% | 3.60M | $187.48M |
| 4 | Capital Research Global Investors | 4.68% | 3.60M | $187.02M |
| 5 | Price (T.Rowe) Associates Inc | 4.04% | 3.11M | $161.54M |
| 6 | Ameriprise Financial, Inc. | 3.46% | 2.66M | $138.21M |
| 7 | Blackrock Inc. | 2.86% | 2.20M | $114.27M |
| 8 | Vanguard Capital Management LLC | 2.43% | 1.86M | $96.91M |
| 9 | Invesco Ltd. | 2.39% | 1.83M | $95.36M |
| 10 | Citadel Advisors Llc | 2.09% | 1.61M | $83.66M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ARXS
Arxis: A Business System Generating Sticky, Annuity-Like Revenue Stream (NASDAQ:ARXS) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxPRXBwRkZaRjhVNHhNNTY1V1p5bWEzWExrNDV4Z1pZckdaU1hUQzdfNEptZTVSbDhSbmQ3cUFKY3RxUE9aN29iTVpBZDlwQ3JVaFR2ejY4bkZrejYwLV9GeUZaSlhJazhHUXR1UHBVQ2xhdjNkY3F2WWJrZlZQLVJaUEdIWHZHbDBrWkVCWm…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE5EalN2TXFzc202RmVqc3RkWjhSdUhpNzlEUGh2SWpHZjFESGxnbGhqNTBPdmxBUnFTRk1Fb1N0RVlHVDkxN1pzbldCQ2hJUGYt?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Assessing Arxis (ARXS) Valuation After A Sharp Short Term Share Price Rally - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxPZXBxenVLTmdXenRINk9tSXVpNDZ6a3BBcnB1ZWR5QXNCTDV0RExUeXNiOG96YTVobFJBMnB3RlBKUUhkS2hWZVEyN0V0RGxiMnp4SEFrS2lnVm0xanFIUHNZNlYyTk9TTlhPaWlSUVNTNkFEQzdXdmpSbTE1UjdqMmZuYjE0NlhkUHVHcG…
Arxis adds two parts makers for aerospace, defense and space, expected to generate over $40M in fiscal 2027 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxQQm1nUnF4QktBNDFrU3ZaUHcwUm41X1JiTC1mVkEwNEhZdXV0U2NsZ2lOQjAwTlRlTHhRWGxEZkloYXZOSFgzb2F6Wjg1ZVlXcEdxOGs4RzF1THRrcHF2c19VTjJsZEZMdGhySDRUZGpKSnVacS1tdmREdkRVNXBCZjZZWng4NEpFamNtQU…
$ARXS stock is up 17% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxOekNrY0dSa3VlNXlBZzhXSlREd3ByNmNiVEVVQkZTSUNaNHNlSEduaWNrZWNLYWxnMWNQMFpEX1hUYVN5aTVUWXVaV0xrdjRHblNBZ1Z2S0xENEs3SGtsa0QwVndLdzJ4MDlUd2dDNVNFazZGY2NQNFJELTZxamg1MVVYQ1BmWWNpWGN4R2…
ARXS Stock Price and Chart — NASDAQ:ARXS - tradingview.com
<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTFBVRjZjOWFFcTlNMm1LOGhLMnNOdjJxS1U1UGsxRE5NTWZVZllFZUxBcmdHdkxYX0taajhUcXJQVDluNVNZVEhlaGlPckhlaWNQcWF4Q1NoSGV1V1NW?oc=5" target="_blank">ARXS Stock Price and Chart — NASDAQ:ARXS</a…
ARXS — Frequently Asked Questions
What is the current share price of Arxis, Inc. (ARXS)?
As of 2026-09-19 21:16 PDT, Arxis, Inc. (ARXS) trades at $53.19 on NasdaqGS. Its 52-week range is $34.05 to $59.99.
What is the market capitalisation of ARXS?
Arxis, Inc. (ARXS) has a market capitalisation of $4.80B on NasdaqGS.
What is the P/E ratio of ARXS?
ARXS trades at a trailing price-to-earnings (P/E) ratio of 759.86. The industry average P/E is 26.00. Its price-to-book (P/B) ratio is 4.90.
What is the return on equity (ROE) of ARXS?
ARXS has a return on equity (ROE) of -1.19%. Its return on capital employed (ROCE) is 1.62%.
Is ARXS a good stock to buy?
This page provides a data-driven analysis of Arxis, Inc. (ARXS), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.